WESTON, Fla., May 9, 2025 /PRNewswire/ - Apotex Corp. today launched IVRA™ (Melphalan) hydrochloride injection 90mg/ml multidose vial ("IVRA"), first ready-to-dilute liquid formulation of ...

Doxorubicin is a type of anthracycline chemotherapy drug used to treat certain types of solid tumors and blood cancers. It has a number of side effects, some more serious than others. Experts ...

Doxorubicin hydrochloride was immediately dissolved in ddH 2 O to ... and the retention time of TALA (10 mM, injection volume 1 μL) was recorded by TOFMS. Then, the CMC system was rebalanced with the ...

One lot of Phenylephrine hydrochloride Injection, USP, 10 mg/mL is being recalled due to particulate matter found in a vial. Provepharm announced on Jan. 24, 2025 that it has voluntarily recalled one ...

Credit: Provepharm Inc Phenylephrine hydrochloride is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. The recall ...

Lupin Ltd. launched a generic cancer treatment drug in the US market on Wednesday. The firm launched Doxorubicin Hydrochloride Liposome Injection in single-dose vials in the US drug market. The drug ...

Global pharma major Lupin Limited (Lupin) announced the launch of doxorubicin hydrochloride liposome injection 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials in the United States, ...

Lupin’s alliance partner, ForDoz has received approval from the Food and Drug Administration for doxorubicin hydrochloride liposome injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL ...

today announced the ANDA approval of DOXOrubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) from the United States Food and Drug Administration (US FDA).

Mumbai: Global pharma major Lupin Limited has announced that its alliance partner, ForDoz Pharma Corporation, USA has received approval from the United States Food and Drug Administration (U.S. FDA) ...